Selegiline reduces adiposity induced by high‐fat, high‐sucrose diet in male rats

BACKGROUND AND PURPOSE: Incidence and severity of obesity are increasing worldwide, however, efficient and safe pharmacological treatments are not yet available. Certain MAO inhibitors reduce body weight, although their effects on metabolic parameters have not been investigated. Here, we have assess...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Pharmacol
Auteurs principaux: Nagy, Csilla Terézia, Koncsos, Gábor, Varga, Zoltán V, Baranyai, Tamás, Tuza, Sebestyén, Kassai, Ferenc, Ernyey, Aliz Judit, Gyertyán, István, Király, Kornél, Oláh, Attila, Radovits, Tamás, Merkely, Béla, Bukosza, Nóra, Szénási, Gábor, Hamar, Péter, Mathé, Domokos, Szigeti, Krisztián, Pelyhe, Csilla, Jelemenský, Marek, Onódi, Zsófia, Helyes, Zsuzsanna, Schulz, Rainer, Giricz, Zoltán, Ferdinandy, Péter
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Research Papers
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6109222/
https://ncbi.nlm.nih.gov/pubmed/29971762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14437
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires